Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Biochemistry

• Publication date

  1998-03-10

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI972010RPMID 9521660
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polynucleotide modulation of the protease, nucleoside triphosphatase, and helicase activities of a hepatitis C virus NS3-NS4A complex isolated from transfected COS cells

  1997cited by this paper
• Structure of the hepatitis C virus RNA helicase domain

  1997cited by this paper
• Probing the substrate specificity of hepatitis C virus NS3 serine protease by using synthetic peptides

  1997cited by this paper
• In Vitro Activity of Hepatitis C Virus Protease NS3 Purified from Recombinant Baculovirus-infected Sf9 Cells (*)

  1996cited by this paper
• AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR

  1996cited by this paper
• The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site.

  1996cited by this paper
• Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease

  1996cited by this paper
• Enzymatic characterization of hepatitis C virus NS3/4A complexes expressed in mammalian cells by using the herpes simplex virus amplicon system

  1996cited by this paper
• Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide.

  1996cited by this paper
• Expression, isolation, and characterization of the hepatitis C virus ATPase/RNA helicase.

  1995cited by this paper
• C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity.

  1995cited by this paper
• The N-terminal region of hepatitis C virus nonstructural protein 3 (NS3) is essential for stable complex formation with NS4A

  1995cited by this paper
• Interferon therapy in chronic hepatitis C virus infection.

  1994cited by this paper
• Comparative mapping of recombinant proteins and glycoproteins by plasma desorption and matrix-assisted laser desorption/ionization mass spectrometry.

  1994cited by this paper
• Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins

  1994cited by this paper
• NS3 is a serine protease required for processing of hepatitis C virus polyprotein

  1993cited by this paper
• Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions

  1993cited by this paper
• Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites

  1993cited by this paper
• A second hepatitis C virus-encoded proteinase.

  1993cited by this paper
• A self-consistent method for the analysis of protein secondary structure from circular dichroism.

  1993cited by this paper
• A new RNA helicase isolated from HeLa cells that catalytically translocates in the 3' to 5' direction.

  1992cited by this paper
• Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease

  1991cited by this paper
• Structure and organization of the hepatitis C virus genome isolated from human carriers

  1991cited by this paper
• Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates.

  1991cited by this paper
• A second group of hepatitis C viruses

  1991cited by this paper
• Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis.

  1991cited by this paper
• Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.

  1990cited by this paper
• Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

  1989cited by this paper
• Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.

  1989cited by this paper
• Peptide and protein mapping by 252Cf-plasma desorption mass spectrometry.

  1988cited by this paper

• Investigating the effect of polymerase inhibitors on cellular proliferation: Computational studies, cytotoxicity, CDK1 inhibitory potential, and LC‐MS/MS cancer cell entrapment assays

  2024cites this paper
• Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses.

  2023cites this paper
• Hepatitis E Virus Cysteine Protease Has Papain Like Properties Validated by in silico Modeling and Cell-Free Inhibition Assays

  2020cites this paper
• CLONEO GENOME OF INFECTIOUS HEPATITUS C VIRUS OF GENOTYPE 2A AND USES THEREOF

  2017cites this paper
• Hepatitis C Virus: Structural Insights into Protease Inhibitor Efficacy and Drug Resistance: A Dissertation

  2015cites this paper
• Nonstructural Protein 5A (NS5A) and Human Replication Protein A Increase the Processivity of Hepatitis C Virus NS5B Polymerase Activity In Vitro

  2014cites this paper
• pH-Dependent Conformational Changes in the HCV NS3 Protein Modulate Its ATPase and Helicase Activities

  2014cites this paper
• Development of boceprevir: a first‐in‐class direct antiviral treatment for chronic hepatitis C infection

  2013cites this paper
• Chapter 688 – Hepacivirin

  2013cites this paper
• The Discovery and Development of Boceprevir: A Novel, First-generation Inhibitor of the Hepatitis C Virus NS3/4A Serine Protease

  2013cites this paper
• Understanding the structural and energetic basis of inhibitor and substrate bound to the full-length NS3/4A: insights from molecular dynamics simulation, binding free energy calculation and network analysis.

  2012cites this paper
• Recent Progress in the Development of HCV Protease Inhibitors

  2011cites this paper
• Production of protein complexes via co-expression.

  2011cites this paper
• Cell defense systems against oxidative stress and endoplasmic reticulum stress: Mechanisms of regulation and the effect of hepatitis C virus

  2011cites this paper
• Discovery and Development of Telaprevir

  2011cites this paper
• In-cell selectivity profiling of membrane-anchored and replicase-associated hepatitis C virus NS3-4A protease reveals a common, stringent substrate recognition profile

  2011cites this paper
• in press-uncorrected proof In-cell selectivity profiling of membrane-anchored and replicase-associated hepatitis C virus NS 3-4 A protease reveals a common , stringent substrate recognition profile

  2011cites this paper
• [Cellular defense systems against oxidative and ER stresses: mechanisms of regulation and influence of hepatitis C virus].

  2011cites this paper
• Hepatitis C virus NS3 protease is activated by low concentrations of protease inhibitors.

  2009cites this paper
• Identification of amino acid variants in the hepatitis C virus non-structural protein 4A.

  2009cites this paper
• The NS4A Protein of Hepatitis C Virus Promotes RNA-Coupled ATP Hydrolysis by the NS3 Helicase

  2009cites this paper
• Inhibition and binding kinetics of the hepatitis C virus NS3 protease inhibitor ITMN-191 reveals tight binding and slow dissociative behavior.

  2009cites this paper
• Hepatitis C Viral NS3-4A Protease Activity Is Enhanced by the NS3 Helicase*S⃞

  2008cites this paper
• Development of a protease production platform for structure-based drug design.

  2007cites this paper
• Resistance Profiling of Hepatitis C Virus Protease Inhibitors using Full-Length NS3

  2007cites this paper
• The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target.

  2007cites this paper
• Effects on protease inhibition by modifying of helicase residues in hepatitis C virus nonstructural protein 3

  2007cites this paper
• Identification and characterization of the NTPase activity of classical swine fever virus (CSFV) nonstructural protein 3 (NS3) expressed in bacteria

  2007cites this paper
• Congenital and other related infectious diseases of the newborn

  2007cites this paper
• Hepatitis B Virus and Hepatitis C Virus: Molecular Biology and Diagnosis

  2006cites this paper
• Multiple Full-length NS3 Molecules Are Required for Optimal Unwinding of Oligonucleotide DNA in Vitro*

  2005cites this paper
• Stimulation of Hepatitis C Virus (HCV) Nonstructural Protein 3 (NS3) Helicase Activity by the NS3 Protease Domain and by HCV RNA-Dependent RNA Polymerase

  2005cites this paper
• Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells.

  2005cites this paper
• Hepatitis C virus NS3 RNA helicase activity is modulated by the two domains of NS3 and NS4A.

  2004cites this paper
• Expression and purification of a hepatitis C virus NS3/4A complex, and characterization of its helicase activity with the Scintillation Proximity Assay system.

  2004cites this paper
• The Nonstructural Protein 3 Protease/Helicase Requires an Intact Protease Domain to Unwind Duplex RNA Efficiently*

  2004cites this paper
• Structural biology of hepatitis C virus

  2004cites this paper
• Enhanced nucleic acid binding to ATP-bound hepatitis C virus NS3 helicase at low pH activates RNA unwinding.

  2004influential citation
• In vitro assay for HCV serine proteinase expressed in insect cells.

  2003cites this paper
• Enzymatic properties of hepatitis C virus NS3 serine protease and bio-engineering of serine protease inhibitors (serpins) against the NS3 protease and elastase

  2003cites this paper
• Expression and purification of recombinant full-length NS3 protease-helicase from a new variant of Hepatitis C virus.

  2002cites this paper
• Establishment of a simple assay in vitro for hepatitis C virus NS3 serine protease based on recombinant substrate and single-chain protease.

  2002cites this paper
• The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding

  2002cites this paper
• Enhanced kinetic extraction of parvovirus B19 structural proteins.

  2002cites this paper
• Inhibitors of hepatitis C virus NS3.4A protease: an overdue line of therapy.

  2002cites this paper
• Hepatitis Viruses

  2002cites this paper
• Antiviral Agents for Hepatitis Viruses

  2002cites this paper
• The inhibition of cAMP-dependent protein kinase by full-length hepatitis C virus NS3/4A complex is due to ATP hydrolysis.

  2001cites this paper
• Recent advances in the molecular biology of hepatitis C virus.

  2001cites this paper
• A personal account of the role of peptide research in drug discovery: the case of hepatitis C 1

  2001cites this paper
• Emerging therapies for hepatitis C virus infection

  2001influential citation
• Role of charged residues in the catalytic mechanism of hepatitis C virus NS3 protease: electrostatic precollision guidance and transition-state stabilization.

  2001cites this paper
• Effect of naturally occurring active site mutations on hepatitis C virus NS3 protease specificity

  2001cites this paper
• Genome clone du virus de l'hepatite c de genotype 2a et son utilisation

  2000cites this paper
• Amantadine and rimantadine have no direct inhibitory effects against hepatitis C viral protease, helicase, ATPase, polymerase, and internal ribosomal entry site-mediated translation.

  2000cites this paper
• Perspectives for the Treatment of Infections withFlaviviridae

  2000cites this paper
• Probing the Active Site of the Hepatitis C Virus Serine Protease by Fluorescence Resonance Energy Transfer*

  2000cites this paper
• Hepatitis C NS3 protease: restoration of NS4A cofactor activity by N-biotinylation of mutated NS4A using synthetic peptides.

  2000cites this paper
• Virus-Specific Cofactor Requirement and Chimeric Hepatitis C Virus/GB Virus B Nonstructural Protein 3

  2000cites this paper
• Cross-genotypic interaction between hepatitis C virus NS3 protease domains and NS4A cofactors.

  2000cites this paper
• Purified NS2B/NS3 Serine Protease of Dengue Virus Type 2 Exhibits Cofactor NS2B Dependence for Cleavage of Substrates with Dibasic Amino Acids in Vitro*

  2000cites this paper
• Perspectives for the treatment of infections with Flaviviridae.

  2000cites this paper
• Novel Approaches to the Treatment of Hepatitis C Virus Infection

  2000cites this paper
• Expression and purification of an active, full-length hepatitis C viral NS4A.

  2000cites this paper
• Development of a High Throughput Scintillation Proximity Assay for Hepatitis C Virus NS3 Protease That Reduces the Proportion of Competitive Inhibitors Identified

  2000cites this paper
• Probing the relationship between RNA-stimulated ATPase and helicase activities of HCV NS3 using 2'-O-methyl RNA substrates.

  2000cites this paper
• A high-throughput radiometric assay for hepatitis C virus NS3 protease.

  1999cites this paper
• A novel recombinant single‐chain hepatitis C virus ns3‐ns4a protein with improved helicase activity

  1999cites this paper
• Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase.

  1999cites this paper
• A continuous spectrophotometric assay for the hepatitis C virus serine protease.

  1999cites this paper
• Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A.

  1999cites this paper
• Proteases of the Hepatitis C Virus

  1999cites this paper
• Functional Expression of Recombinant Proteases

  1999cites this paper
• Chapter 13. Progress in the Search for Anti-HCV Therapeutics

  1999cites this paper
• The non‐structural 5A protein of hepatitis C virus

  1999cites this paper
• Flaviviridae with Perspectives for the Treatment of Infections

  1999cites this paper
• Engineering, characterization and phage display of hepatitis C virus NS3 protease and NS4A cofactor peptide as a single-chain protein.

  1998cites this paper
• Construction, expression, and characterization of a novel fully activated recombinant single‐chain hepatitis C virus protease

  1998cites this paper
• Rational design and functional expression of a constitutively active single-chain NS4A-NS3 proteinase.

  1998cites this paper
• The Hepatitis C Virus NS3 Proteinase: Structure and Function of a Zinc-Containing Serine Proteinase

  1998cites this paper
• Emerging targets in the treatment of hepatitis C virus infection

  1998cites this paper